SOCIETE DE THERAPEUTIQUE MAROCAINE S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,011 MAD | +1.10% |
|
+6.31% | +6.31% |
| Sales 2023 * | - | Sales 2024 * | - | Capitalization | 7.28B 73.77B |
|---|---|---|---|---|---|
| Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | - |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
| P/E ratio 2023 * |
24.8
x | P/E ratio 2024 * |
22
x | Employees | - |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 10.68% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | +1.10% | ||
| 1 week | +6.31% | ||
| Current month | -0.39% | ||
| 1 month | -2.79% | ||
| 3 months | -3.62% | ||
| 6 months | -1.84% | ||
| Current year | +6.31% |
1 week
951.00
1 025.00
1 month
923.001 039.00
Current year
923.001 065.00
1 year
923.001 348.00
3 years
887.501 750.00
5 years
375.001 750.00
10 years
278.751 750.00
| Managers | Title | Age | Since |
|---|---|---|---|
Lamia Tazi
CEO | Chief Executive Officer | 47 | 97-10-05 |
Adnane Hilal
DFI | Director of Finance/CFO | - | - |
Mehdi Zaghloul
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mohamed Tazi
BRD | Director/Board Member | - | - |
Bahia Berrada
BRD | Director/Board Member | - | - |
| Director/Board Member | - | 07-06-06 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 1,011 | +1.10% | 946 |
| 24-04-18 | 1,000 | +1.73% | 4,086 |
| 24-04-17 | 983 | +2.72% | 33 |
| 24-04-16 | 957 | -2.35% | 108 |
End-of-day quote Casablanca S.E., April 18, 2024
More quotes
Sothema (Société de Thérapeutique Marocaine) is No. 1 in Morocco of manufacturing and marketing licensed pharmaceutical products and biotechnology drugs. The group's activity is organized around 3 areas:
- drug sales: products made under license and under own names;
- importing and sales of drugs, dental products, and ophthalmic equipment;
- subcontractor fabrication of pharmaceutical products: services provided to Moroccan and foreign laboratories.
At the end of 2019, Sothema had 6 production units located in Morocco.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1,011
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +6.31% | 711M | |
| +24.60% | 672B | |
| +24.08% | 550B | |
| -5.63% | 351B | |
| +15.37% | 317B | |
| +7.38% | 292B | |
| +3.26% | 211B | |
| +0.78% | 203B | |
| -9.69% | 144B | |
| -6.63% | 141B |
- Stock Market
- Equities
- SOT Stock
